Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Trump’s pick to lead NIH, Dr. Jay Bhattacharya, confirmed by Senate in party-line vote

by admin March 26, 2025
March 26, 2025
Trump’s pick to lead NIH, Dr. Jay Bhattacharya, confirmed by Senate in party-line vote

The full Senate voted Tuesday evening to confirm President Donald Trump’s pick to lead the National Institutes of Health (NIH), Dr. Jay Bhattacharya.

The party-line vote followed approval from the Senate Committee on Health, Education, Labor and Pensions, which also voted along party lines to advance Bhattacharya, leading to today’s full Senate vote.  

A physician, Stanford professor of medicine and senior fellow at the university’s Institute for Economic Policy Research, Bhattacharya was a leading voice during the COVID-19 pandemic against lockdown measures and vaccine mandates. 

He was one of the co-authors of the Great Barrington Declaration, a document published in October 2020 by a group of scientists advocating against widespread COVID lockdowns and promoting the efficacy of natural immunity for low-risk individuals as opposed to vaccination.

Bhattacharya was probed by the Senate HELP Committee earlier this month over various issues related to his potential role as NIH director. However, for much of the hearing, he was forced to defend the president’s decision to cut certain research funds at NIH, including a 15% cap on indirect research costs, also known as facilities and administrative costs, dispersed by the NIH.

Bhattacharya would not explicitly say he disagreed with the cuts, or that, if confirmed, he would step in to stop them. Rather, he said he would ‘follow the law,’ while also investigating the effect of the cuts and ensuring every NIH researcher doing work that advances the health outcomes of Americans has the resources necessary.

‘I think transparency regarding indirect costs is absolutely worthwhile. It’s something that universities can fix by working together to make sure that where that money goes is made clear,’ Bhattacharya said of the indirect costs going to universities, hospitals and research clinics from the NIH. 

In addition to addressing questions about the Trump cuts, Bhattacharya also laid out what he called a new, decentralized vision for future research at NIH that he said will be aimed at embracing dissenting ideas and transparency, while focusing on research topics that have the best chance at directly benefiting health outcomes of Americans. Bhattacharya added that he wants to rid the agency’s research portfolio of other ‘frivolous’ efforts that he says do little to directly benefit health outcomes.

‘I think fundamentally what matters is do scientists have an idea that advances the scientific field they’re in?’ Bhattacharya said last week during his confirmation testimony. ‘Do they have an idea that ends up addressing the health needs of Americans?’

Prior to his confirmation, Bhattacharya, alongside several other scientists, including Trump’s pick to head the Food and Drug Administration, Dr. Marty Makary, launched a new research journal focused on spurring scientific discourse and combating ‘gatekeeping’ in the medical research community. The journal, the Journal of the Academy of Public Health (JAPH), aims to spur scientific discourse by publishing peer reviews of prominent studies from other journals that do not make their peer reviews publicly available.

This post appeared first on FOX NEWS

previous post
Jordan Roy-Byrne: Gold Stocks in “Sweet Spot,” Setting Up for Hot Run
next post
Trump FDA pick clears last hurdle after flipping vaccine question on Dem in confirmation hearing

Related Posts

Trump pauses aid to Ukraine after fiery meeting...

March 4, 2025

Sparks expected to fly at Kash Patel’s Senate...

January 30, 2025

When it comes to ID, it’s time to...

May 1, 2025

Trump: Jimmy Carter died a happy man because...

April 18, 2025

‘Too aggressive militarily’: Trump talks Hegseth’s role pardoning...

March 4, 2025

Trump says deal with Ukraine for US access...

February 22, 2025

Elon Musk outlines ‘super obvious’ changes DOGE and...

February 10, 2025

Trump says career gov employees working on policy...

April 19, 2025

Here’s what happened during Trump’s 3rd week in...

February 8, 2025

SCOOP: Inside progressives’ plan to have ‘thousands’ protest...

April 25, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 2

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 3

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved